ReviewFrontiers in bioengineering and biotechnology2020
The Gibberellin Producer
Review in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 57 citations in OpenAlex.
- Metabolic Engineering for Gibberellic Acid Production inMolecules (Basel, Switzerland) · 2026Review
- Development of a CRISPRi system inEngineering microbiology · 2026Article
- Biotechnological Potential of the Fusarium fujikuroi Complex From Amazonian Oenocarpus bacaba: Lipase Production and Characterization.Journal of basic microbiology · 2025Article
- Identification of a novel phenuivirus with an unusual ambisense genome from the ascomycete fungus Fusarium fujikuroi.Archives of virology · 2025Article
- Biofilm Formation in Clinical Isolates ofJournal of fungi (Basel, Switzerland) · 2024Article
- The TOR signalling pathway in fungal phytopathogens: A target for plant disease control.Molecular plant pathology · 2024Review
- Fungal Diversity and Gibberellin Hormones Associated with Long Whips of Smut-Infected Sugarcanes.International journal of molecular sciences · 2024Article
- Annotating Multiple Prebiotic Synthesizing Capabilities Through Whole Genome Sequencing of Fusarium Strain HFK-74.Applied biochemistry and biotechnology · 2024Article
- Bioprocess of Gibberellic Acid byJournal of fungi (Basel, Switzerland) · 2024Review
- Insights into the cumulative effect of Colletotrichum gloeosporioides and Fusarium acutatum causing anthracnose-twister disease complex of onion.Scientific reports · 2024Article
- Establishment of a selectable marker recycling system for iterative gene editing inSynthetic and systems biotechnology · 2024Article
- Long-term conservation tillage with reduced nitrogen fertilization intensity can improve winter wheat health via positive plant-microorganism feedback in the rhizosphere.FEMS microbiology ecology · 2024Article
- Fusaric acid-evoked oxidative stress affects plant defence system by inducing biochemical changes at subcellular level.Plant cell reports · 2023Review
- Understanding the Fermentation Potentiality For Gibberellic Acid (GACurrent microbiology · 2023Review
- The ATP Synthase SubunitsInternational journal of molecular sciences · 2023Article
- Genome mining of3 Biotech · 2022Article
- Whole-Genome Sequencing and Comparative Genome Analysis of Fusarium solani-melongenae Causing Fusarium Root and Stem Rot in Sweetpotatoes.Microbiology spectrum · 2022Article
- Sensitivity Testing of Natural Antifungal Agents onJournal of fungi (Basel, Switzerland) · 2022Article
- Review
- Physiological and metabolic analyses provide insight into soybean seed resistance toFrontiers in plant science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, there has been a noticeable increase in research interests on the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.